
معرفی
Christian Rocheleau, PhD is a Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) at the Glen site and an Associate Professor in the Department of Medicine, Faculty of Medicine and Health Sciences at McGill University. He is affiliated with the Metabolic Disorders and Complications Program within the Centre for Translational Biology and the Department of Medicine, Division of Endocrinology at the MUHC.
Dr. Rocheleau's research focuses on understanding the mechanisms that regulate two fundamental cellular processes: cell signaling and protein trafficking, and the interactions between these processes. His laboratory uses the nematode Caenorhabditis elegans as a model system to study gene function at both cellular and organismal levels. The high conservation of genes between C. elegans and humans means that findings from his research have direct relevance to human health.
His work primarily investigates EGFR signaling pathways, Rab GTPases, and vesicular trafficking mechanisms in C. elegans. His recent publications demonstrate a consistent focus on how trafficking regulators like TBC-2, RAB proteins, and LIN complexes influence developmental processes, stress resistance, and longevity through pathways involving DAF-16/FOXO transcription factors. His research has important implications for understanding human diseases related to cell signaling and trafficking defects.
Dr. Rocheleau's laboratory serves as a training ground for graduate students and postdoctoral fellows interested in cell biology, genetics, and molecular mechanisms of development. His work is supported by various research grants that enable his team to investigate the intricate connections between cellular trafficking pathways and developmental signaling.
The Rocheleau lab is part of the Metabolic Disorders and Complications Program at the RI-MUHC, where they collaborate with other researchers studying metabolic diseases, endocrinology, and translational medicine. Their work bridges fundamental cell biology with potential clinical applications in understanding human metabolic disorders.